公司资料
Serina Therapeutics 股价、新闻与催化剂
- 股票代码:
- SER
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.20 USD (-11.11%)
收盘价
最后更新: 2026年11月19日
—
市值
股价为何变动
截至 2026年11月19日,SER 下跌 11.1%,收于 $1.20。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
AgeX Therapeutics was a regenerative medicine company focused on cellular rejuvenation and tissue repair biology. Its narrative centered on early-stage platform science rather than a broad commercial asset base.
所在地与行业分类
AgeX was headquartered in the United States and traded on NASDAQ. It sat in the regenerative-biotech and early platform development segment.
商业模式特征
The business depended on preclinical validation, translational progress, and the ability to attract enough capital to keep the platform alive. Investors typically looked at scientific updates, financing, and strategic optionality.
生物医药行业定位
AgeX occupied a speculative early-stage regenerative-medicine niche within biotech. The stock profile was defined by long-dated science and high execution risk.
未来催化剂
- AgeX is largely a legacy and closeout story, with catalysts tied to any strategic or asset-resolution update. The market is not treating it like a live growth name.
近期新闻
新闻标题由机器翻译,详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。
